08:00 , Nov 16, 2015 |  BC Week In Review  |  Company News

Astellas, Leo Pharma deal

Leo Pharma will acquire the global dermatology business of Astellas for EUR675 million ($726.6 million). Astellas’ dermatology portfolio includes Protopic, a topical formulation of the immunosuppressant tacrolimus to treat eczema, and Locoid hydrocortisone...
01:29 , Nov 12, 2015 |  BC Extra  |  Company News

Leo buys Astellas' dermatology business

Leo Pharma A/S (Ballerup, Denmark) will acquire the global dermatology business of Astellas Pharma Inc. (Tokyo:4503) for EUR 675 million ($726.6 million). Astellas' dermatology portfolio includes Protopic, a topical formulation of immunosuppressant tacrolimus to treat...
08:00 , Feb 10, 2014 |  BC Week In Review  |  Company News

PreCision Dermatology, Valeant Pharmaceuticals deal

Valeant will acquire dermatology company PreCision for $475 million in cash, plus up to an additional $25 million in sales-based milestones. PreCision markets dermatology products, including mid-potency topical steroid Locoid, BenzEFoam Emollient Foam...
07:00 , May 14, 2012 |  BC Week In Review  |  Company News

PreCision Dermatology, Triax Pharmaceuticals LLC deal

PreCision acquired the assets of Triax for an undisclosed sum. Triax markets branded prescription dermatology products, including Locoid, a mid-potency topical steroid, and acne treatments Minocin and Tretin X. PreCision's prescription dermatology subsidiary...
07:00 , Oct 8, 2007 |  BC Week In Review  |  Clinical News

NCX 1022: Phase I data

NicOx S.A. (Euronext:COX), Sophia-Antipolis, France   Ferrer Internacional S.A., Barcelona, Spain   Product: NCX 1022   Business: Dermatology   Molecular target: Cyclooxygenases (COX)   Description: Nitric oxide (NO)-releasing derivative of hydrocortisone   Indication: Treat seborrheic dermatitis, atopic dermatitis and psoriasis...
07:00 , May 28, 2007 |  BC Week In Review  |  Clinical News

Locoid hydrocortisone butyrate regulatory update

FDA approved an NDA for topical Locoid hydrocortisone butyrate 0.1% to treat mild to moderate atopic dermatitis in patients 3 months of age and older. Ferndale Laboratories Inc., Ferndale, Mich.   Product: Locoid hydrocortisone butyrate...